[srp post_limit=”1″ widget_title=”” thumbnail_height=”300″ thumbnail_width=”300″ wp_thumbnail_size=”medium” ext_shortcodes_compatibility=”yes” post_content_length=”” post_content_length_mode=”” post_content_type=”” post_title_length_mode=”words” string_break=”” title_string_break=”” post_author_url=”no” post_category_link=”no” widget_title_hide=”yes” post_title_header=”h3″]

Aldatu Biosciences Secures Impact-Driven Investment as a Public Benefit Corporation

Cambridge, Mass. (June 3, 2016) – (download press release .pdf) Aldatu Biosciences, a Cambridge-based biotechnology company developing diagnostic tools to address unmet clinical needs in global health, recently received a program-related investment (PRI) from CH Innovations (a subsidiary of the Charles H. Hood Foundation), a Boston based organization whose mission is to fund entrepreneurial efforts to improve the health and quality of life …
Read More

Aldatu Biosciences Licenses PANDAA Technology from Harvard University

Aldatu Biosciences (Aldatu) has licensed intellectual property developed in Professor Max Essex’s laboratory at the Harvard T.H. Chan School of Public Health. The intellectual property includes a novel qPCR-based genotyping platform, PANDAA, for the detection of single nucleotide polymorphisms (SNPs) in pathogen genomes, for use in the development of research tools and clinical diagnostics for infectious disease. Aldatu is currently applying PANDAA …
Read More

Q&A: A New Test For Drug-Resistant HIV Breaks All the Scientific Rules

Q&A: A New Test For Drug-Resistant HIV Breaks All the Scientific Rules …
Read More

Aldatu Selected for AdvaMed 2015 Innovation Showcase

Washington, DC, 18th September 2015 (download press release .pdf) AdvaMed 2015: The MedTech Conference, the leading gathering of medical technology professionals in North America, has awarded 48 scholarships to early and development stage medical device, diagnostic and health IT companies to present at the conference in San Diego from October 5-7. “Exposure at conferences like AdvaMed 2015 is crucial for early stage medical …
Read More

Aldatu Named a 2015 RESI Innovator

Cambridge, MA, 1st September 2015 Aldatu was selected to participate in the Innovation Challenge as part of the Redefining Early State Investments (RESI) Conference being held in Boston on September 16th, 2015. Aldatu will join 29 other innovative life science companies in therapeutics, diagnostics, medical devices, and healthcare IT tracks in an exhibition-style presentation format throughout the day-long conference. Aldatu Biosciences is an …
Read More